Clinical Trials at Weill Cornell Medicine
As of September 2026, 108 paid clinical trials are recruiting at Weill Cornell Medicine, located at 1305 YORK AVE, 5TH FLOOR, NEW YORK, NY 10021-5663, phone (646) 962-3681 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
110 clinical trials at Weill Cornell Medicine
·Clear filters·A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
BioHealx® Anal Fistula Device Post Market Surveillance Study
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
RESET System Pivotal Trial (Rev F)
Digital Tools to Support Healthcare Decision Making
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
Integrated PTSD and Chronic Pain Treatment
Kaempferol Absorption and Pharmacokinetics Evaluation
Precision-Based Genomics in Prostate Cancer
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Improving the Heart Health of Home Health Aides
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
Engage & Connect: A Psychotherapy for Postpartum Depression
Improving the Mental Health of Home Health Aides
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (44 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (41 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,383 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (44), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,132), Neurology & pain (198), Cardiovascular (195). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Weill Cornell Medicine?
Weill Cornell Medicine is located at 1305 YORK AVE, 5TH FLOOR, NEW YORK, NY 10021-5663. Use the Google Maps link in the intro above to get directions.
How do I contact Weill Cornell Medicine?
You can reach Weill Cornell Medicine by phone at (646) 962-3681. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.